A common KIF6 polymorphism increases vulnerability to low-density lipoprotein cholesterol: Two meta-analyses and a meta-regression analysis

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Ference, Brian A ^a,b   Yoo, Wonsuk ^a,c   Flack, John M ^a   Clarke, Michael ^b,d,e  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRYPTOPHAN; KIF6 PROTEIN, HUMAN; KINESIN;

ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DNA MODIFICATION; DNA POLYMORPHISM; GENE; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; KINESIN LIKE PROTEIN 6 GENE; META ANALYSIS; PREDICTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; TREATMENT RESPONSE; BLOOD; GENETIC POLYMORPHISM; GENETICS; PHYSIOLOGY;

CHOLESTEROL, LDL; HUMANS; KINESIN; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS;

EID: 83755186157     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028834     Document Type: Article

References (35)

1. Iakoubova OA, Tong CH, Rowland CM, Kirchgessner TG, Young BA, et al. (2008) Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. J Am Coll Cardiol 51 (4): 435-443.
2. Shiffman D, Sabatine MS, Louie JZ, Kirchgessner TG, Iakoubova OA, et al. (2010) Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial. Am J Cardiol 105 (9): 1300-1305.
3. Iakoubova OA, Sabatine MS, Rowland CM, Tong CH, Catanese JJ, et al. (2008) Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. J Am Coll Cardiol 51 (4): 449-455.
4. Iakoubova OA, Robertson M, Tong CH, Rowland CM, Catanese JJ, et al. (2010) KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study. Eur J Cardiovasc Prev Rehabil 17 (4): 455-461.
5. Hopewell JC, Parish S, Clarke R, Armitage J, Bowman L, et al. (2011) No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study. MRC/BHF Heart Protection Study Collaborative Group. J Am Coll Cardiol 57 (20): 2000-2007.
6. Ridker PM, Macfadyen JG, Glynn RJ, Chasman DI, (2011) Kinesin-Like Protein 6 (KIF6) Polymorphism and the Efficacy of Rosuvastatin in Primary Prevention. Circ Cardiovasc Genet 4 (3): 312-317.
7. Topol EJ, Damani SB, (2010) The KIF6 collapse. J Am Coll Cardiol 56 (19): 1564-1566.
8. Li Y, Iakoubova OA, Shiffman D, Devlin JJ, Forrester JS, et al. (2010) A KIF6 polymorphism as a predictor of risk of coronary events and of clinical event reduction by statin therapy. Am J Cardiol 106 (7): 994-998.
9. Li Y, Sabatine MS, Tong CH, Ford I, Kirchgessner TG, et al. (2011) Genetic variants in the KIF6 region and coronary event reduction from statin therapy. Hum Genet 129 (1): 17-23.
10. Morrison AC, Bare LA, Chambless LE, Ellis SG, Malloy M, et al. (2007) Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 166 (1): 28-35.
11. Bare LA, Morrison AC, Rowland CM, Shiffman D, Luke MM, et al. (2007) Five common gene variants identify elevated genetic risk for coronary heart disease. Genet Med 9 (10): 682-689.
12. Shiffman D, O'Meara ES, Bare LA, Rowland CM, Louie JZ, et al. (2008) Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 28 (1): 173-179.
13. Shiffman D, Chasman DI, Zee RY, Iakoubova OA, Louie JZ, et al. (2008) A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study. J Am Coll Cardiol 51 (4): 444-448.
14. Assimes TL, Hólm H, Kathiresan S, Reilly MP, Thorleifsson G, et al. (2010) Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol 56 (19): 1552-1563.
15. Scherer RW, Langenberg P, von Elm E, (2007) Full publication of results initially presented in abstracts. Cochrane Database Syst Rev 2: MR000005.
16. Horsley T, Dingwall O, Sampson M, (2011) Checking reference lists to find additional studies for systematic reviews. Cochrane Database Syst Rev 8: MR000026.
17. Salanti G, Sanderson S, Higgins JP, (2005) Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med 7 (1): 13-20.
18. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
19. Sutton AJ, Higgins JP, (2008) Recent developments in meta-analysis. Stat Med 27 (5): 625-650.
20. Thompson SG, Higgins JP, (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21 (11): 1559-1573.
21. Baigent C, Keech A, Kearney PM, Blackwell L, et al. (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (9493): 1267-1278.
22. Baigent C, Blackwell L, Emberson J, Holland LE, et al. Cholesterol Treatment Trialists' (CTT) Collaboration (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376 (9753): 1670-1681.
23. Altman DG, Bland JM, (2003) Interaction revisited: the difference between two estimates. BMJ 326 (7382): 219.
24. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21 (11): 1539-1558.
25. Arsenault B, Boekholdt SM, Hovingh GC, Hyde CL, DeMicco DA, et al. (2011) The Trp719arg Variant of KIF6 and Cardiovascular Outcomes in Statin-Treated, Coronary Stable Patients of the TNT and IDEAL Prospective Studies. J Am Coll Cardiol 57: 1203.
26. Stewart AF, Dandona S, Chen L, Assogba O, Belanger M, et al. (2009) Kinesin family member 6 variant Trp719Arg does not associate with angiographically defined coronary artery disease in the Ottawa Heart Genomics Study. J Am Coll Cardiol 53 (16): 1471-1472.
27. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357: 443-453.
28. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, et al. (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316: 1488-1491.
29. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, et al. (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316: 1491-1493.
30. Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
31. Kathiresan S, Voight BF, Purcell S, Musunuru K, et al. Myocardial Infarction Genetics Consortium (2009) Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 41: 334-341.
32. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937-952.
33. Berglund G, Elmstahl S, Janzon L, Larsson SA, (1993) The Malmo Diet and Cancer Study: Design and feasibility. J Intern Med 233: 45-51.
34. Rothman KJ, Greenland S, Walker AM, (1980) Concepts of interaction. Am J Epidemiol 112 (4): 467-470.
35. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43 (4): 333-338.